Showing results (721-730 of 784) with videos related to

Sort By:
Pageof 79
JAMA Network Open|March 27, 2024
Sitting Time Reduction and Blood Pressure in Older Adults: A Randomized Clinical TrialDori E Rosenberg, Weiwei Zhu, Mikael Anne Greenwood-Hickman, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 10, 2022
Scientific meeting report: International Biochemistry of Exercise 2022Anna Vainshtein, Mikhaela B Slavin, Arthur J Cheng, et al.
American Journal of Physiology. Cell Physiology|January 23, 2023
Mitochondrial creatine sensitivity is lost in the D2.mdx model of Duchenne muscular dystrophy and rescued by the mitochondrial-enhancing compound OlesoximeCatherine A Bellissimo, Luca J Delfinis, Meghan C Hughes, et al.
Scientific Reports|May 8, 2021
Skeletal muscle metabolic responses to physical activity are muscle type specific in a rat model of chronic kidney diseaseKeith G Avin, Meghan C Hughes, Neal X Chen, et al.
American Journal of Physiology. Cell Physiology|December 25, 2023
The slow-release adiponectin analog ALY688-SR modifies early-stage disease development in the D2.mdx mouse model of Duchenne muscular dystrophyCatherine A Bellissimo, Shivam Gandhi, Laura N Castellani, et al.
Current Oncology (Toronto, Ont.)|April 25, 2025
Canadian Expert Consensus Recommendations for the Diagnosis and Management of Glioblastoma: Results of a Delphi StudyWarren P Mason, Rebecca A Harrison, Sarah Lapointe, et al.
Neuro-Oncology|March 13, 2015
Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE studyL Burt Nabors, Karen L Fink, Tom Mikkelsen, et al.
Nature Medicine|August 12, 2025
Lymph node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: phase 1 AMPLIFY-201 trial final resultsZev A Wainberg, Colin D Weekes, Muhammad Furqan, et al.
The Journal of Physiology|November 3, 2025
The mitochondrial-targeted antioxidant SkQ1 prevents skeletal muscle mitochondrial-apoptotic but not necroptotic signalling during ovarian cancerShahrzad Khajehzadehshoushtar, Luca J Delfinis, Fasih A Rahman, et al.
Diabetes|June 21, 2014
Heterozygous SOD2 deletion impairs glucose-stimulated insulin secretion, but not insulin action, in high-fat-fed miceLi Kang, Chunhua Dai, Mary E Lustig, et al.
Pageof 79